LD-2 disclosure · 2nd Quarter - Termination
TERUMO BCT, INC.
via TERUMO BCT, INC.
Client
- Name
- TERUMO BCT, INC.
- Description
- Medical technology company
- Location
- Colorado · United States of America
Registrant
- Firm
- TERUMO BCT, INC.
- Location
- Lakewood, Colorado, United States of America
Lobbying activities
2 issuesHealth Issues
-Access to Therapeutic Apheresis, generally. -Sickle Cell Disease issues, generally; S.1852, Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023. -Blood collection issues, generally. -Medical device sterilization. -ARPA-H, cell collections issues, generally. -H.R.7432, The Sickle Cell Disease Comprehensive Care Act.
LobbyistsANDREA HECHAVARRIA
TargetedSENATE · HOUSE OF REPRESENTATIVES · White House Office · Health & Human Services, Dept of (HHS) · Environmental Protection Agency (EPA)
Medicare/Medicaid
-Access to Therapeutic Apheresis, generally. -Issues related to CY 2024 Physician Fee Schedule. -Issues related to CY 2024 OPPS Proposed Rule. -Sickle Cell Disease issues, generally.
LobbyistsANDREA HECHAVARRIA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS) · Centers For Medicare and Medicaid Services (CMS)